Debate on Transplant Role in T-Cell Lymphoma Treatment

The chapter delves into the ongoing debate regarding upfront transplant versus relapse before transplant for T-cell lymphoma patients, with a focus on older patients and the importance of randomized studies to address bias. It also discusses the challenges and outcomes of autologous and allogeneic transplants for T-cell lymphoma patients, emphasizing the varying responses of different T-cell lymphoma subtypes to allotransplantation and the need for careful patient selection and timing for successful transplants.